Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anteco Pharma was a U.S.-based contract development and manufacturing organization focused on lyophilization, freeze-drying, aseptic processing, fill-finish, formulation, analytical testing, and related manufacturing services for pharmaceutical, biologic, medical device, and specialty nutrition products. The company operated from Lodi, Wisconsin and was founded by industry veterans Howard Teeter and Chris Conlon. Available sources describe Anteco Pharma as serving clients with development and manufacturing support rather than advancing a proprietary therapeutic pipeline. Evidence from bankruptcy records indicates the company filed for Chapter 11 bankruptcy in May 2021 and the case was closed in November 2022, so it appears to be inactive/defunct today. Its historical value proposition centered on specialized lyophilization capabilities and flexible small-company contract manufacturing support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anteco Pharma.